A Phase I Safety Study of NVG-291 in Healthy Adults
NCT05308953
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Spinal Cord Injury
Interventions
DRUG:
NVG-291
OTHER:
Placebo
Sponsor
NervGen Pharma